Ester compound and medicinal use thereof

Details for Australian Patent Application No. 2003211617 (hide)

Owner Japan Tobacco Inc.

Inventors Taniguchi, Toshio; Kawai, Takashi; Ikenogami, Taku; Ohe, Yasuhiro; Madono, Kenya; Odani, Naoya; Watanabe, Shizue; Hagiwara, Atsushi

Agent Griffith Hack

Pub. Number AU-B-2003211617

PCT Number PCT/JP03/02398

PCT Pub. Number WO2003/072532

Priority 2002-53876 28.02.02 JP

Filing date 28 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 2 February 2006

International Classifications

C07C 69/732 (2006.01) Esters of carboxylic acids

A61K 31/215 (2006.01)

A61K 31/216 (2006.01)

A61K 31/235 (2006.01)

A61K 31/24 (2006.01)

A61K 31/245 (2006.01)

A61K 31/277 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/404 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 Drugs for disorders of the metabolism

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 2002-53876 28.02.02 JP

16 October 2003 Application Open to Public Inspection

  Published as AU-B-2003211617

23 October 2003 Application Open to Public Inspection

  Published as AU-B-2003211617

2 February 2006 Application Accepted

  Published as AU-B-2003211617

1 June 2006 Standard Patent Sealed

18 October 2007 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 31 Aug 2007. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

6 March 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 31 Aug 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003211618-METHOD AND ARRANGEMENT FOR PROCESSING STRUCTURED DATA

2003211616-DNA and vector for regulating the expression of lachrymator synthase gene, method of regulating the expression of lachrymator synthase gene using the same, and plant with the regulated expression of lachrymator synthase gene